Coronary heart disease in Indians: implications of the INTERHEART study

Vamadevan S Ajay1, Dorairaj Prabhakaran

  • 1Centre for Chronic Disease Control, New Delhi, India.

Insights

Coronary heart disease (CHD) is a major health issue in India. The INTERHEART study identified modifiable risk factors and a key biomarker, Apo B/ApoA 1 ratio, for predicting and preventing CHD.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary heart diseases (CHD) represent a significant public health challenge in India.
  • Behavioral and conventional risk factors play a crucial role in CHD prediction among the Indian population.

Purpose of the Study:

  • To highlight the implications of the INTERHEART study findings for healthcare providers and policymakers in India.
  • To emphasize the potential for CHD risk reduction through modifiable factors and policy interventions.
  • To underscore the need for enhanced health system strategies for CHD prevention and management.

Main Methods:

  • The study emphasizes findings from the INTERHEART study, focusing on risk factor analysis.
  • It highlights the identification of the Apo B/ApoA 1 ratio as a reliable biomarker for CHD risk prediction.

Main Results:

  • Behavioral and conventional risk factors are key predictors of CHD risk in Indians.
  • The Apo B/ApoA 1 ratio serves as a single, reliable biomarker for predicting future CHD risk.
  • The study identified several unanswered questions regarding the pathobiology of premature myocardial infarction in Indians.

Conclusions:

  • Findings from the INTERHEART study provide a strong rationale for developing CHD treatment algorithms and guidelines.
  • Policy measures targeting agriculture, food, tobacco, and physical activity can significantly reduce population CHD risk.
  • There is a need to develop clinical research capacity in India to address CHD pathobiology and premature myocardial infarction.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...